Statistics for Ideaya Biosciences (id:7903 IDYA)

Valuation metrics

Market cap

2.30B

Enterprise value

1.31B

Trailing P/E (ttm)

-13.67

Forward P/E

-9.78

PEG ratio

-9.78

Price/Sales (ttm)

586.20

Price/Book (mrq)

1.95

Enterprise Value/Revenue

333.05

Enterprise Value/EBITDA

-5.88

Overview

Shares outstanding

86.43M

Float

85.54M

Shares short

9.31M

% Held by insiders

0.01%

% Held by institutions

1.11%

Average volume (10 days)

888.51K

Average volume (90 days)

Price summary

52-Week low

25.20

52-Week high

47.74

52-Week change

-18.22%

Beta

0.86

50-Day moving average

30.79

200-Day moving average

38.19

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

-5,730.60%

Operational effectiveness

Return on assets

-15.85%

Return on equity

-21.10%

Income statement

Revenue (ttm)

0.05

Revenue per share (ttm)

0.05

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-222,310,000.00

Net income to common (ttm)

-178,120,000.00

Diluted EPS (ttm)

-2.33

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

920.03M

Total cash per share (mrq)

10.64

Total debt (mrq)

18.80M

Total Debt/Equity (mrq)

1.59

Current ratio (mrq)

2.29K%

Book value per share (mrq)

13.67

Cash flow

Cash flow statement

-149,676,992.00

Levered free cash flow (LFCF)

-90,681,248.00